Cargando…

Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders

BACKGROUND: Inherited platelet function disorders (PFDs) are heterogeneous, and identification of the underlying genetic defects is difficult when based solely on phenotypic and clinical features of the patient. OBJECTIVE: To analyze 329 genes regulating platelet function, number, and size in order...

Descripción completa

Detalles Bibliográficos
Autores principales: Leo, V. C., Morgan, N. V., Bem, D., Jones, M. L., Lowe, G. C., Lordkipanidzé, M., Drake, S., Simpson, M. A., Gissen, P., Mumford, A., Watson, S. P., Daly, M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383639/
https://www.ncbi.nlm.nih.gov/pubmed/25556537
http://dx.doi.org/10.1111/jth.12836
_version_ 1782364779905548288
author Leo, V. C.
Morgan, N. V.
Bem, D.
Jones, M. L.
Lowe, G. C.
Lordkipanidzé, M.
Drake, S.
Simpson, M. A.
Gissen, P.
Mumford, A.
Watson, S. P.
Daly, M. E.
author_facet Leo, V. C.
Morgan, N. V.
Bem, D.
Jones, M. L.
Lowe, G. C.
Lordkipanidzé, M.
Drake, S.
Simpson, M. A.
Gissen, P.
Mumford, A.
Watson, S. P.
Daly, M. E.
author_sort Leo, V. C.
collection PubMed
description BACKGROUND: Inherited platelet function disorders (PFDs) are heterogeneous, and identification of the underlying genetic defects is difficult when based solely on phenotypic and clinical features of the patient. OBJECTIVE: To analyze 329 genes regulating platelet function, number, and size in order to identify candidate gene defects in patients with PFDs. PATIENTS/METHODS: Targeted analysis of candidate PFD genes was undertaken after next‐generation sequencing of exomic DNA from 18 unrelated index cases with PFDs who were recruited into the UK Genotyping and Phenotyping of Platelets (GAPP) study and diagnosed with platelet abnormalities affecting either Gi signaling (n = 12) or secretion (n = 6). The potential pathogenicity of candidate gene defects was assessed using computational predictive algorithms. RESULTS: Analysis of the 329 candidate PFD genes identified 63 candidate defects, affecting 40 genes, among index cases with Gi signaling abnormalities, while 53 defects, within 49 genes, were identified among patients with secretion abnormalities. Homozygous gene defects were more commonly associated with secretion abnormalities. Functional annotation analysis identified distinct gene clusters in the two patient subgroups. Thirteen genes with significant annotation enrichment for ‘intracellular signaling’ harbored 16 of the candidate gene defects identified in nine index cases with Gi signaling abnormalities. Four gene clusters, representing 14 genes, with significantly associated gene ontology annotations were identified among the cases with secretion abnormalities, the most significant association being with ‘establishment of protein localization.’ CONCLUSION: Our findings demonstrate the genetic complexity of PFDs and highlight plausible candidate genes for targeted analysis in patients with platelet secretion and Gi signaling abnormalities.
format Online
Article
Text
id pubmed-4383639
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-43836392015-04-02 Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders Leo, V. C. Morgan, N. V. Bem, D. Jones, M. L. Lowe, G. C. Lordkipanidzé, M. Drake, S. Simpson, M. A. Gissen, P. Mumford, A. Watson, S. P. Daly, M. E. J Thromb Haemost PLATELETS BACKGROUND: Inherited platelet function disorders (PFDs) are heterogeneous, and identification of the underlying genetic defects is difficult when based solely on phenotypic and clinical features of the patient. OBJECTIVE: To analyze 329 genes regulating platelet function, number, and size in order to identify candidate gene defects in patients with PFDs. PATIENTS/METHODS: Targeted analysis of candidate PFD genes was undertaken after next‐generation sequencing of exomic DNA from 18 unrelated index cases with PFDs who were recruited into the UK Genotyping and Phenotyping of Platelets (GAPP) study and diagnosed with platelet abnormalities affecting either Gi signaling (n = 12) or secretion (n = 6). The potential pathogenicity of candidate gene defects was assessed using computational predictive algorithms. RESULTS: Analysis of the 329 candidate PFD genes identified 63 candidate defects, affecting 40 genes, among index cases with Gi signaling abnormalities, while 53 defects, within 49 genes, were identified among patients with secretion abnormalities. Homozygous gene defects were more commonly associated with secretion abnormalities. Functional annotation analysis identified distinct gene clusters in the two patient subgroups. Thirteen genes with significant annotation enrichment for ‘intracellular signaling’ harbored 16 of the candidate gene defects identified in nine index cases with Gi signaling abnormalities. Four gene clusters, representing 14 genes, with significantly associated gene ontology annotations were identified among the cases with secretion abnormalities, the most significant association being with ‘establishment of protein localization.’ CONCLUSION: Our findings demonstrate the genetic complexity of PFDs and highlight plausible candidate genes for targeted analysis in patients with platelet secretion and Gi signaling abnormalities. John Wiley and Sons Inc. 2015-01-27 2015-04 /pmc/articles/PMC4383639/ /pubmed/25556537 http://dx.doi.org/10.1111/jth.12836 Text en © 2014 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle PLATELETS
Leo, V. C.
Morgan, N. V.
Bem, D.
Jones, M. L.
Lowe, G. C.
Lordkipanidzé, M.
Drake, S.
Simpson, M. A.
Gissen, P.
Mumford, A.
Watson, S. P.
Daly, M. E.
Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
title Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
title_full Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
title_fullStr Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
title_full_unstemmed Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
title_short Use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
title_sort use of next‐generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders
topic PLATELETS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383639/
https://www.ncbi.nlm.nih.gov/pubmed/25556537
http://dx.doi.org/10.1111/jth.12836
work_keys_str_mv AT leovc useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT morgannv useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT bemd useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT jonesml useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT lowegc useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT lordkipanidzem useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT drakes useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT simpsonma useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT gissenp useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT mumforda useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT watsonsp useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT dalyme useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders
AT useofnextgenerationsequencingandcandidategeneanalysistoidentifyunderlyingdefectsinpatientswithinheritedplateletfunctiondisorders